Loading…

Use of venovenous (VV) extracorporeal membrane oxygenation (ECMO) in near-fatal asthma: a case series

Status asthmaticus (SA) and near-fatal asthma (NFA) are life-threatening conditions that continue to present a management challenge for physicians. Extracorporeal Membrane Oxygenation (ECMO) has been employed as a last resort in treating these patients. We described six patients who were admitted to...

Full description

Saved in:
Bibliographic Details
Published in:Multidisciplinary respiratory medicine 2024-02, Vol.19 (1), p.943
Main Authors: Ibarra, Ciro D, Sangiovanni, Saveria, Bautista, Diego F, Calderón-Miranda, Camilo A, Cruz, Gustavo A, Fernández-Trujillo, Liliana
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c314t-726ff25b105fc9e5550a392593fab961289d06aa304e40f15d1805c7a50f7113
cites
container_end_page
container_issue 1
container_start_page 943
container_title Multidisciplinary respiratory medicine
container_volume 19
creator Ibarra, Ciro D
Sangiovanni, Saveria
Bautista, Diego F
Calderón-Miranda, Camilo A
Cruz, Gustavo A
Fernández-Trujillo, Liliana
description Status asthmaticus (SA) and near-fatal asthma (NFA) are life-threatening conditions that continue to present a management challenge for physicians. Extracorporeal Membrane Oxygenation (ECMO) has been employed as a last resort in treating these patients. We described six patients who were admitted to the ICU for NFA and received ECMO treatment at a high-complexity institution in Cali, Colombia, between 2015 and 2019. All patients are registered in the ELSO registry. Baseline patient characteristics, arterial blood gases (ABG), ventilatory parameters, and complications were collected as specified in the ELSO registry form. Efficacy was analyzed in terms of the improvement in respiratory acidosis, the number of ventilator-free days (VFD), and a reduction in mechanical power (MP). MP, which refers to the energy associated with the mechanical forces involved in breathing and the functioning of the respiratory system, was calculated using a mathematical formula. Safety was evaluated based on the incidence of complications. After 12 hours of ECMO, we achieved a correction of respiratory acidosis, a significant decrease in all ventilatory parameters, and a reduction in MP ranging from 52.8% to 89%. There was one mortality. Among the five surviving patients, all except one, who required a tracheostomy, had a high VFD score, with a mode of 26 days, demonstrating a reduction in ventilation time. Further randomized controlled trials are needed to fully understand the efficacy and safety profiles of ECMO in SA/NFA. MP is being widely used to achieve safer ventilation, and although more data is required, it appears to be a promising option for evaluating the risk of developing VILI and the success of the therapy.
doi_str_mv 10.5826/mrm.2024.943
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10929514</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>38476128</sourcerecordid><originalsourceid>FETCH-LOGICAL-c314t-726ff25b105fc9e5550a392593fab961289d06aa304e40f15d1805c7a50f7113</originalsourceid><addsrcrecordid>eNpVkE1Lw0AQhhdRbKm9eZY9VjB1P5OsF5FSP6DSSy3elkm620aapOympf33bqgWXRh2YN55Z-ZB6JqSoUxZfF-6csgIE0Ml-BnqMiJUFCuZnqMuTVna5p8d1Pf-i4QXS8qluEQdnookpiztIvPhDa4t3pmqbmPr8WA-v8Vm3zjIa7epnYE1Lk2ZOaiCdH9Ymgqaoq7wYDx6n97iosKVARdZaIISfLMq4QEDziFYe-MK46_QhYW1N_2fv4dmz-PZ6DWaTF_eRk-TKOdUNFHCYmuZzCiRNldGSkmAKyYVt5CpdmG1IDEAJ8IIYqlc0JTIPAFJbEIp76HHo-1mm5VmkZsqHLHWG1eU4A66hkL_r1TFSi_rnaZEMSWpCA53R4fc1d47Y0_NlOiWuA7EdUtcB-JBfvN34En8y5d_A-SSfM8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Use of venovenous (VV) extracorporeal membrane oxygenation (ECMO) in near-fatal asthma: a case series</title><source>PubMed Central</source><creator>Ibarra, Ciro D ; Sangiovanni, Saveria ; Bautista, Diego F ; Calderón-Miranda, Camilo A ; Cruz, Gustavo A ; Fernández-Trujillo, Liliana</creator><creatorcontrib>Ibarra, Ciro D ; Sangiovanni, Saveria ; Bautista, Diego F ; Calderón-Miranda, Camilo A ; Cruz, Gustavo A ; Fernández-Trujillo, Liliana</creatorcontrib><description>Status asthmaticus (SA) and near-fatal asthma (NFA) are life-threatening conditions that continue to present a management challenge for physicians. Extracorporeal Membrane Oxygenation (ECMO) has been employed as a last resort in treating these patients. We described six patients who were admitted to the ICU for NFA and received ECMO treatment at a high-complexity institution in Cali, Colombia, between 2015 and 2019. All patients are registered in the ELSO registry. Baseline patient characteristics, arterial blood gases (ABG), ventilatory parameters, and complications were collected as specified in the ELSO registry form. Efficacy was analyzed in terms of the improvement in respiratory acidosis, the number of ventilator-free days (VFD), and a reduction in mechanical power (MP). MP, which refers to the energy associated with the mechanical forces involved in breathing and the functioning of the respiratory system, was calculated using a mathematical formula. Safety was evaluated based on the incidence of complications. After 12 hours of ECMO, we achieved a correction of respiratory acidosis, a significant decrease in all ventilatory parameters, and a reduction in MP ranging from 52.8% to 89%. There was one mortality. Among the five surviving patients, all except one, who required a tracheostomy, had a high VFD score, with a mode of 26 days, demonstrating a reduction in ventilation time. Further randomized controlled trials are needed to fully understand the efficacy and safety profiles of ECMO in SA/NFA. MP is being widely used to achieve safer ventilation, and although more data is required, it appears to be a promising option for evaluating the risk of developing VILI and the success of the therapy.</description><identifier>ISSN: 1828-695X</identifier><identifier>EISSN: 2049-6958</identifier><identifier>DOI: 10.5826/mrm.2024.943</identifier><identifier>PMID: 38476128</identifier><language>eng</language><publisher>Italy: PAGEPress Publications, Pavia, Italy</publisher><subject>Case Report</subject><ispartof>Multidisciplinary respiratory medicine, 2024-02, Vol.19 (1), p.943</ispartof><rights>Copyright © 2024, the Author(s).</rights><rights>Copyright © 2024, the Author(s) 2024 Licensee PAGEPress, Italy</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c314t-726ff25b105fc9e5550a392593fab961289d06aa304e40f15d1805c7a50f7113</citedby><orcidid>0000-0002-0677-6948 ; 0000-0003-0789-9154 ; 0009-0003-9332-2294 ; 0000-0001-7902-3341</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10929514/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10929514/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38476128$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ibarra, Ciro D</creatorcontrib><creatorcontrib>Sangiovanni, Saveria</creatorcontrib><creatorcontrib>Bautista, Diego F</creatorcontrib><creatorcontrib>Calderón-Miranda, Camilo A</creatorcontrib><creatorcontrib>Cruz, Gustavo A</creatorcontrib><creatorcontrib>Fernández-Trujillo, Liliana</creatorcontrib><title>Use of venovenous (VV) extracorporeal membrane oxygenation (ECMO) in near-fatal asthma: a case series</title><title>Multidisciplinary respiratory medicine</title><addtitle>Multidiscip Respir Med</addtitle><description>Status asthmaticus (SA) and near-fatal asthma (NFA) are life-threatening conditions that continue to present a management challenge for physicians. Extracorporeal Membrane Oxygenation (ECMO) has been employed as a last resort in treating these patients. We described six patients who were admitted to the ICU for NFA and received ECMO treatment at a high-complexity institution in Cali, Colombia, between 2015 and 2019. All patients are registered in the ELSO registry. Baseline patient characteristics, arterial blood gases (ABG), ventilatory parameters, and complications were collected as specified in the ELSO registry form. Efficacy was analyzed in terms of the improvement in respiratory acidosis, the number of ventilator-free days (VFD), and a reduction in mechanical power (MP). MP, which refers to the energy associated with the mechanical forces involved in breathing and the functioning of the respiratory system, was calculated using a mathematical formula. Safety was evaluated based on the incidence of complications. After 12 hours of ECMO, we achieved a correction of respiratory acidosis, a significant decrease in all ventilatory parameters, and a reduction in MP ranging from 52.8% to 89%. There was one mortality. Among the five surviving patients, all except one, who required a tracheostomy, had a high VFD score, with a mode of 26 days, demonstrating a reduction in ventilation time. Further randomized controlled trials are needed to fully understand the efficacy and safety profiles of ECMO in SA/NFA. MP is being widely used to achieve safer ventilation, and although more data is required, it appears to be a promising option for evaluating the risk of developing VILI and the success of the therapy.</description><subject>Case Report</subject><issn>1828-695X</issn><issn>2049-6958</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpVkE1Lw0AQhhdRbKm9eZY9VjB1P5OsF5FSP6DSSy3elkm620aapOympf33bqgWXRh2YN55Z-ZB6JqSoUxZfF-6csgIE0Ml-BnqMiJUFCuZnqMuTVna5p8d1Pf-i4QXS8qluEQdnookpiztIvPhDa4t3pmqbmPr8WA-v8Vm3zjIa7epnYE1Lk2ZOaiCdH9Ymgqaoq7wYDx6n97iosKVARdZaIISfLMq4QEDziFYe-MK46_QhYW1N_2fv4dmz-PZ6DWaTF_eRk-TKOdUNFHCYmuZzCiRNldGSkmAKyYVt5CpdmG1IDEAJ8IIYqlc0JTIPAFJbEIp76HHo-1mm5VmkZsqHLHWG1eU4A66hkL_r1TFSi_rnaZEMSWpCA53R4fc1d47Y0_NlOiWuA7EdUtcB-JBfvN34En8y5d_A-SSfM8</recordid><startdate>20240213</startdate><enddate>20240213</enddate><creator>Ibarra, Ciro D</creator><creator>Sangiovanni, Saveria</creator><creator>Bautista, Diego F</creator><creator>Calderón-Miranda, Camilo A</creator><creator>Cruz, Gustavo A</creator><creator>Fernández-Trujillo, Liliana</creator><general>PAGEPress Publications, Pavia, Italy</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0677-6948</orcidid><orcidid>https://orcid.org/0000-0003-0789-9154</orcidid><orcidid>https://orcid.org/0009-0003-9332-2294</orcidid><orcidid>https://orcid.org/0000-0001-7902-3341</orcidid></search><sort><creationdate>20240213</creationdate><title>Use of venovenous (VV) extracorporeal membrane oxygenation (ECMO) in near-fatal asthma: a case series</title><author>Ibarra, Ciro D ; Sangiovanni, Saveria ; Bautista, Diego F ; Calderón-Miranda, Camilo A ; Cruz, Gustavo A ; Fernández-Trujillo, Liliana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c314t-726ff25b105fc9e5550a392593fab961289d06aa304e40f15d1805c7a50f7113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Case Report</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ibarra, Ciro D</creatorcontrib><creatorcontrib>Sangiovanni, Saveria</creatorcontrib><creatorcontrib>Bautista, Diego F</creatorcontrib><creatorcontrib>Calderón-Miranda, Camilo A</creatorcontrib><creatorcontrib>Cruz, Gustavo A</creatorcontrib><creatorcontrib>Fernández-Trujillo, Liliana</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Multidisciplinary respiratory medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ibarra, Ciro D</au><au>Sangiovanni, Saveria</au><au>Bautista, Diego F</au><au>Calderón-Miranda, Camilo A</au><au>Cruz, Gustavo A</au><au>Fernández-Trujillo, Liliana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use of venovenous (VV) extracorporeal membrane oxygenation (ECMO) in near-fatal asthma: a case series</atitle><jtitle>Multidisciplinary respiratory medicine</jtitle><addtitle>Multidiscip Respir Med</addtitle><date>2024-02-13</date><risdate>2024</risdate><volume>19</volume><issue>1</issue><spage>943</spage><pages>943-</pages><issn>1828-695X</issn><eissn>2049-6958</eissn><abstract>Status asthmaticus (SA) and near-fatal asthma (NFA) are life-threatening conditions that continue to present a management challenge for physicians. Extracorporeal Membrane Oxygenation (ECMO) has been employed as a last resort in treating these patients. We described six patients who were admitted to the ICU for NFA and received ECMO treatment at a high-complexity institution in Cali, Colombia, between 2015 and 2019. All patients are registered in the ELSO registry. Baseline patient characteristics, arterial blood gases (ABG), ventilatory parameters, and complications were collected as specified in the ELSO registry form. Efficacy was analyzed in terms of the improvement in respiratory acidosis, the number of ventilator-free days (VFD), and a reduction in mechanical power (MP). MP, which refers to the energy associated with the mechanical forces involved in breathing and the functioning of the respiratory system, was calculated using a mathematical formula. Safety was evaluated based on the incidence of complications. After 12 hours of ECMO, we achieved a correction of respiratory acidosis, a significant decrease in all ventilatory parameters, and a reduction in MP ranging from 52.8% to 89%. There was one mortality. Among the five surviving patients, all except one, who required a tracheostomy, had a high VFD score, with a mode of 26 days, demonstrating a reduction in ventilation time. Further randomized controlled trials are needed to fully understand the efficacy and safety profiles of ECMO in SA/NFA. MP is being widely used to achieve safer ventilation, and although more data is required, it appears to be a promising option for evaluating the risk of developing VILI and the success of the therapy.</abstract><cop>Italy</cop><pub>PAGEPress Publications, Pavia, Italy</pub><pmid>38476128</pmid><doi>10.5826/mrm.2024.943</doi><orcidid>https://orcid.org/0000-0002-0677-6948</orcidid><orcidid>https://orcid.org/0000-0003-0789-9154</orcidid><orcidid>https://orcid.org/0009-0003-9332-2294</orcidid><orcidid>https://orcid.org/0000-0001-7902-3341</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1828-695X
ispartof Multidisciplinary respiratory medicine, 2024-02, Vol.19 (1), p.943
issn 1828-695X
2049-6958
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10929514
source PubMed Central
subjects Case Report
title Use of venovenous (VV) extracorporeal membrane oxygenation (ECMO) in near-fatal asthma: a case series
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T10%3A16%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20of%20venovenous%20(VV)%20extracorporeal%20membrane%20oxygenation%20(ECMO)%20in%20near-fatal%20asthma:%20a%20case%20series&rft.jtitle=Multidisciplinary%20respiratory%20medicine&rft.au=Ibarra,%20Ciro%20D&rft.date=2024-02-13&rft.volume=19&rft.issue=1&rft.spage=943&rft.pages=943-&rft.issn=1828-695X&rft.eissn=2049-6958&rft_id=info:doi/10.5826/mrm.2024.943&rft_dat=%3Cpubmed_cross%3E38476128%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c314t-726ff25b105fc9e5550a392593fab961289d06aa304e40f15d1805c7a50f7113%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/38476128&rfr_iscdi=true